TDP2 WT and TDP2 KD RM-1 cells were subcutaneously injected into immunocompetent C57BL/6J mice and immunodeficient nude mice, with tumor growth progress monitored regularly (Fig 5A and 5D). This evidence concerns the gene TDP2 and neoplasm.